(Q37761464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

review article

1 reference

title

Perspectives of CCK antagonists in pancreatic research and clinical use. Part I (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

Rovati LC

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 April 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Pancreatology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

215-226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2051061%20AND%20SRC:MED&resulttype=core&format=json

Actions of derivatives of cyclic nucleotides on dispersed acini from guinea pig pancreas. Discovery of a competitive antagonist of the action of cholecystokinin

9 October 2019

cites work

1 reference

12 December 2020

Distinct cholecystokinin receptors in brain and pancreas

1 reference

12 December 2020

Regulation of growth and differentiation in pancreatic cancer. Bethesda, Maryland, September 19 and 20, 1988

1 reference

12 December 2020

Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2.

1 reference

12 December 2020

Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels

1 reference

12 December 2020

Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion

1 reference

12 December 2020

Inhibition of gastric secretion by anti-gastrinic and H2-blocking agents

1 reference

12 December 2020

Stimulation of pancreatic secretion in man by a protease inhibitor (camostate)

1 reference

12 December 2020

Effects of loxiglumide on gallbladder emptying in healthy volunteers.

1 reference

12 December 2020

Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide

1 reference

12 December 2020

Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat.

1 reference

12 December 2020

Low plasma cholecystokinin response after ingestion of a test meal in patients with chronic pancreatitis

1 reference

12 December 2020

Loxiglumide protects against experimental pancreatitis

1 reference

12 December 2020

Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans

1 reference

12 December 2020

Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

1 reference

12 December 2020

Diet, alcohol, tobacco and risk of cancer of the pancreas: a case-control study

1 reference

12 December 2020

Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.

1 reference

12 December 2020

Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.

1 reference

12 December 2020

Promotion by unsaturated fat of azaserine-induced pancreatic carcinogenesis in the rat

1 reference

12 December 2020

Dietary habits and past medical history as related to fatal pancreas cancer risk among adventists

1 reference

12 December 2020

In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist

1 reference

12 December 2020

Androgen influence on exocrine pancreatic cancer

1 reference

12 December 2020

Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas

1 reference

12 December 2020

Proglumide treatment in bile-induced acute experimental pancreatitis

1 reference

12 December 2020

Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats

1 reference

12 December 2020

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

1 reference

12 December 2020

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists

1 reference

12 December 2020

Pharmacokinetics of loxiglumide after single intravenous or oral doses in man

1 reference

12 December 2020

Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis

1 reference

12 December 2020

Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster

1 reference

12 December 2020

Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs

1 reference

12 December 2020

Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model.

1 reference

12 December 2020

Role of cholecystokinin in regulation of gastrointestinal motor functions

1 reference

12 December 2020

Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.

1 reference

12 December 2020

Plasma cholecystokinin levels in patients with chronic pancreatitis

1 reference

12 December 2020

Cholecystokinin in plasma

1 reference

12 December 2020

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus

1 reference

12 December 2020

Effects on exocrine and endocrine rat pancreas of long-term administration of CCK-PZ (cholecystokinin-pancreozymin) or synthetic octapeptide - CCK-PZ

1 reference

12 December 2020

Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis.

1 reference

12 December 2020

New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity

1 reference

12 December 2020

Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity

1 reference

12 December 2020

Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility

1 reference

12 December 2020

Anticholecystokinin activities of loxiglumide.

1 reference

12 December 2020

Structural features of various proglumide-related cholecystokinin receptor antagonists.

1 reference

12 December 2020

Treatment of acute pancreatitis. Comparison of animal and human studies.

1 reference

12 December 2020

Treatment of biliary colic with loxiglumide

1 reference

12 December 2020

Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.

1 reference

12 December 2020

Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation.

1 reference

12 December 2020

Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas

1 reference

12 December 2020

Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans

1 reference

12 December 2020

Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin

1 reference

12 December 2020

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

1 reference

12 December 2020

An epidemiological evaluation of the causes of cancer of the pancreas

1 reference

12 December 2020

Cell site and time course of DNA synthesis in pancreas after caerulein and secretin

1 reference

12 December 2020

Plasma CCK levels in patients with pancreatic insufficiency.

1 reference

12 December 2020

Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats

1 reference

12 December 2020

Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice

1 reference

12 December 2020

Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas

1 reference

12 December 2020

Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays

1 reference

12 December 2020

The Effect of Long-Term Administration of Lorglumide (CR 1409) on Rat Pancreatic Growth and Enzyme Composition

1 reference

12 December 2020

Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist

1 reference

12 December 2020

High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain.

1 reference

12 December 2020

Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors

1 reference

12 December 2020

Physiopathogenic basis of alcoholic pancreatitis: the effects of elevated cholinergic tone and increased "pancreon" ecbolic response to CCK-PZ

1 reference

12 December 2020

Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice

1 reference

12 December 2020

Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamsters.

1 reference

12 December 2020

CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.

1 reference

12 December 2020

Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog

1 reference

12 December 2020

Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists

1 reference

12 December 2020

Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist

1 reference

12 December 2020

Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex

1 reference

12 December 2020

Cholecystokinin antagonists

1 reference

12 December 2020

Protease-specific suppression of pancreatic exocrine secretion

1 reference

12 December 2020

Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists

1 reference

12 December 2020

Atypical and neoplastic acinar cell lesions of the pancreas in an autopsy study of Japanese patients

1 reference

12 December 2020

Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man

1 reference

12 December 2020

Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas

1 reference

12 December 2020

Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180.

1 reference

12 December 2020

Adult cystic fibrosis: postprandial response of gut regulatory peptides

1 reference

12 December 2020

Identifiers

1 reference